Key facts
- This page summarizes Thomas D. Carey's Form 4 filing for EXACT SCIENCES CORP (EXAS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2021, 16:03.
Thomas D. Carey - 02 Jun 2021 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)
- Reporting relationship
- Director
- Issuer ticker
- EXAS
- Reported as of
- 02 Jun 2021
- Net transaction value
- -$1,837,870
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2021, 16:03:08 UTC
- Next SEC filing
- 07 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Carey by Mark Busch, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas D. Carey filed Form 4 for EXACT SCIENCES CORP (EXAS) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$1,837,870.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXAS
transaction
Common Stock
Sale
- Transaction value
- $1,837,870
- Shares
- -17,000
- Change %
- -76%
- Price
- $108.11
- Shares after
- 5,292
- Date
- 02 Jun 2001
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan.